Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Technology Information Technology Services
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(337)
•••
Comment by u2bobon Dec 17, 2018 10:11am
68 Views
Post# 29123291

RE:Question why ?

RE:Question why ?Good Question TBM...

 

Diagnos 6.65-million-share private placement

 

2018-12-14 20:33 ET - Private Placement

 

The TSX Venture Exchange has accepted for filing the documentation with respect to a non-brokered private placement.

 

Number of shares:  6.65 million common shares

Purchase price:  five cents per common share

Warrants:  6.65 million warrants to purchase 6.65 million common shares

Warrant exercise price:  six cents until June 12, 2020

Number of placees:  one placee

Insider/pro group participation:  none

Finder's fee:  none

 

The company has confirmed the closing of the private placement in a news release dated Dec. 12, 2018.

© 2018 Canjex Publishing Ltd. All rights reserved.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities